Article
Tom Caravela
The most difficult parts of being an MSL and how to overcome them
Summary
In this episode, Tom Caravela speaks with Jonathan Horvath about his career journey and insights from the Rutgers fellowship program. Jonathan discusses the complexities and challenges of the MSL role, including organization, territory management, and building relationships with key opinion leaders (KOLs). He addresses internal pressures, performance metrics, and shares strategies for effective time and travel management to combat MSL burnout. The conversation explores navigating different KOL personalities and preparing for meetings. Jonathan also reflects on adapting to COVID-19 and future interactions, offering final advice for aspiring and current MSLs.
My guest today is Jonathan Horvath, former Director of Field Medical Affairs at Dova Pharmaceuticals and we discuss the most difficult parts of being an MSL and how to overcome them.
In this episode we discuss:
- Jonathan’s background
- One of the most challenging parts of being an MSL in his perspective
- KOL access
- The internal pressures and how to overcome
- Other challenges and difficulties that MSLs should be aware of to try to stay on top
- His advice on “MSL frustrations”
- Advice for MSLs moving into 2021 hopefully coming out of COVID pandemic for them to perform well and get through the challenges
- One piece of advice for MSLs to help them find success
MSL career, KOL relationships, MSL challenges, time management strategies, overcoming MSL burnout
Related Topics
You May Also Like
Tom Caravela
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Podcast
MSL Talk: Tom Caravela, Sarah Snyder
The Ideal Roadmap for New MSLs
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li